SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-104033
Filing Date
2024-09-05
Accepted
2024-09-05 16:26:14
Documents
1
Period of Report
2024-09-04

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3435
  Complete submission text file 0000950170-24-104033.txt   4849
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Issuer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 85 WELLS AVENUE NEWTON MA 02459
Business Address
Paulson Richard A. (Reporting) CIK: 0001804460 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36167 | Film No.: 241281708